Despite Steep Discounts, Humira Biosimilars Are Priced More Than Original Originator Price
July 21st 2023Even at a steep discount, the list prices of new adalimumab biosimilars are significantly higher than the original price of the originator product (Humira), highlighting how dramatically its list price has risen over the years.
Read More
Insurers supervising the health care of Medicaid patients repeatedly reject providers’ approval of care; individuals are more likely to develop dementia if they live in disadvantaged neighborhoods; a type of an immunity gene is found in people who test positive for COVID-19 but don’t develop symptoms.
Read More
What We’re Reading: Extreme Heat; Alzheimer Drug Shows Promise; Flood of Mental Health Care Seekers
July 19th 2023Extreme heat prompts doctors to use body bags as cooling devices for heat stroke; a study of the effect of donanemab on the early stages of Alzheimer disease looks promising; UnitedHealth Group is seeing an influx of people seeking mental health care services, causing accessibility issues because of the provider shortage.
Read More
Common CVD Biomarkers May Hold Prognostic Value in MDS, Study Finds
July 19th 2023The findings suggest that circulating N-terminal pro-B-type natriuretic peptide and growth differentiation factor-15, both soluble biomarkers of cardiovascular disease (CVD), may be indicators of the course of myelodysplastic syndromes (MDS) and outcomes.
Read More
Not Just a Hair Cut; An Initiative
July 18th 2023On this episode of Managed Care Cast, we talk with 2 individuals who were essential in the creation and implementation of the Health Access Initiative for Recovery (Our HAIR), launched by Community Care Behavioral Health Organization of Pittsburgh, Pennsylvania.
Listen